Skip to content
10-K

Annual Report

RA PHARMACEUTICALS, INC.

0001047469-19-000968

← back to feed
Filed
Mar 7, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Mar 1, 2019 42.19M sh
Capex FY 2018 · Dec 31, 2017 $1.41M
Operating Cash Flow FY 2018 · Dec 31, 2017 −$46.78M
Cash And Equivalents FY 2018 · Dec 31, 2017 $70.38M
Current Liabilities FY 2018 · Dec 31, 2017 $8.61M
Total Liabilities FY 2018 · Dec 31, 2017 $11.01M
Current Assets FY 2018 · Dec 31, 2017 $72.88M
Total Assets FY 2018 · Dec 31, 2017 $80.2M
Sga Expense FY 2018 · Dec 31, 2017 $9.78M
Rd Expense FY 2018 · Dec 31, 2017 $45.25M
Net Income FY 2018 · Dec 31, 2017 −$15.14M
Net Income FY 2018 · Dec 31, 2017 −$54.44M
Net Income FY 2018 · Sep 30, 2017 −$15.28M
Net Income FY 2018 · Jun 30, 2017 −$12.66M
Net Income FY 2018 · Mar 31, 2017 −$11.36M
Operating Income FY 2018 · Dec 31, 2017 −$55.03M
Stockholders Equity FY 2018 · Dec 31, 2016 $117.22M